CaryRx cover feature

CaryRx

Tech Enabled, On-Demand Pharmacy with Free Same-Day Delivery
$153,465 Raised
Ended April 21st
180 Investors

Pharmacies are overdue for a digital upgrade. We're a full-service pharmacy in the palm of your hand that is reimagining the patient experience. Prescribers send us your prescriptions. Simply order them in our mobile app and watch them come to your door. We offer free delivery in Washington D.C. via Postmates, and two-day shipping to Maryland and Virginia. With a lifetime value of $330 and 99% retention rate for our 1,400 patients, we are ready to expand CaryRx's operations. 

Why you may want to invest
  1. 99%+ customer retention rate.

  2. To date, filled 5k+ prescriptions for over 1,400 patients. 

  3. First pharmacy to partner with Postmates to automate prescription delivery logistics.

  4. Within 7 months of launching, annual revenue run rate is nearly $500k. 

  5. Competitive advantage: we're the only on-demand pharmacy startup led by a pharmacist (9+ years experience). 

  6. Competitive advantage: We are the only pharmacy in the space currently offering both on-demand delivery and two-day shipping.  

  7. Proprietary platform developed by a seasoned tech team, includes: fulfillment platform for pharmacy, iOS/Android mobile apps and mobile app for delivery team. The CaryRx platform was made ready to scale to multiple pharmacy locations. 

  8. Partners can grow with us as we scale: Postmates currently operates in 550 cities and McKesson (our drug supplier) is one of largest in the U.S. 

Learn more about this company

Company Details

Location
Washington, DC
Founded
2015
Employees
2

Key Team Members

Areo Nazari
CEO
Kevin Lance
Head of Growth

Financials

Most recent Fiscal Year

Income Statement

Revenue
$58,646
Cost of Goods Sold
$57,209
Gross Profit
$1,437
Taxes
171%
$475
Net Income
158%
-$137,476

Balance Sheet

Total Assets
133%
$156,075
Cash
2640%
$15,950
Accounts Receivable
$0
Short Term Debt
977%
$119,224
Long Term Debt
253%
$161,375

Other popular startups

Get email updates for the latest investment opportunities
Email
Email